ORACLE INVESTMENT MANAGEMENT INC Hedge Fund

CIK: 0001012622 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value ($000): $602,930 (100.0% shares, 0.0% debt)

Holdings (17)

TESARO INC 27.8%
Value ($000) $167,843 Shares 1,248,086 Est. Cost $12810.39 Unrealized
ACCELERATE DIAGNOSTICS INC 17.3%
Value ($000) $104,422 Shares 5,032,389 Est. Cost $24998.12 Unrealized
NXSTAGE MEDICAL INC 11.8%
Value ($000) $71,334 Shares 2,721,636 Est. Cost $12876.33 Unrealized
MAZOR ROBOTICS LTD 9.9%
Value ($000) $59,621 Shares 2,719,942 Est. Cost $11234.47 Unrealized
QUIDEL CORP 8.9%
Value ($000) $53,926 Shares 2,517,554 Est. Cost $25530.00 Unrealized
OPK OPKO HEALTH INC 5.5%
Value ($000) $32,871 Shares 3,534,539 Est. Cost $7.38 Unrealized +40.2%
AMARIN CORP PLC 4.1%
Value ($000) $24,440 Shares 7,935,000 Est. Cost $680.25 Unrealized
PACB PACIFIC BIOSCIENCES CALIF IN 3.5%
Value ($000) $20,964 Shares 5,516,894 Est. Cost $5.80 Unrealized +25.3%
BIOLASE INC 3.4%
Value ($000) $20,471 Shares 14,622,050 Est. Cost $1097.01 Unrealized
INTREXON CORP 3.3%
Value ($000) $19,940 Shares 820,590 Est. Cost $4275.17 Unrealized
VERMILLION INC 1.4%
Value ($000) $8,193 Shares 8,624,225 Est. Cost $1646.88 Unrealized
AGENUS INC 1.3%
Value ($000) $7,935 Shares 1,925,918 Est. Cost $986.80 Unrealized
ARAY ACCURAY INC 1.1%
Value ($000) $6,858 Shares 1,490,879 Est. Cost $5.71 Unrealized -9.1%
CONTRAFECT CORP 0.3%
Value ($000) $2,069 Shares 1,182,032 Est. Cost $5.25 Unrealized
BIIB BIOGEN INC 0.3%
Value ($000) $1,907 Shares 6,723 Est. Cost $213.68 Unrealized +38.7%
SECOND SIGHT MED PRODS INC 0.0%
Value ($000) $100 Shares 50,804 Est. Cost $10.26 Unrealized
ZIOPHARM ONCOLOGY INC 0.0%
Value ($000) $36 Shares 6,661 Est. Cost $12.00 Unrealized